Publication | Closed Access

Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE

Hematological MalignancyRadiation OncologyCell TherapyOncologyMarrow TransplantationTransplantationRelapsed Multiple MyelomaHealth SciencesHematologyLenalidomide MaintenanceBlood TransplantationImmunotherapyMedicineCell TransplantationSalvage Autologous Transplant